Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Kipfer, C. Maier, M. Büchler, T. Bodmer (Thun, Bern, Switzerland). Effect of isoniazid prophylaxis for latent TB on interferon-gamma response. Eur Respir J 2007; 30: Suppl. 51, 259

Member's Comments

No comment yet.

Related content which might interest you: Effect of isoniazid on antigen-specific interferon-? secretion in latent tuberculosis Source: Eur Respir J 2015; 45: 473-482 Year: 2015 Evaluation of therapeutic response in isoniazid resistant TB Source: Eur Respir J 2006; 28: Suppl. 50, 846s Year: 2006 Screening for latent TB using antigen-specific IP-10 response and the effect of prednisolon Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2012 Latent tuberculosis (infection). Evaluation of a short course treatment with isoniazid, rifampin and pyrazinamid Source: Eur Respir J 2002; 20: Suppl. 38, 567s Year: 2002 Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005 Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs Source: Eur Respir J, 55 (3) 1902048; 10.1183/13993003.02048-2019 Year: 2020 Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population Source: Eur Respir J 2005; 26: Suppl. 49, 624s Year: 2005 Isoniazid hepatotoxicity associated with treatment of latent tuberculosis in patients on anti-TNF treatment Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 Modulation of whole-blood IGRA response in patients with latent TB infection during treatment Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Dosage of isoniazid and rifampicin poorly predicts drug exposure in tuberculosis patients Source: Eur Respir J 2016; 48: 1237-1239 Year: 2016 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Two months isoniazid, rifampin and pirazinamid for latent tuberculosis infection Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010 IP-10 decreases during antituberculous treatment in children with active tuberculosis. Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020 Patient choice promotes adherence in preventive treatment for latent tuberculosis Source: Eur Respir J 2007; 30: 728-735 Year: 2007 Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Efficacy of anti-tuberculosis therapy with INH, RIF and Bedaquiline in mice with different genetic susceptibility to the infection Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment Source: International Congress 2017 – Migrants and screening Year: 2017 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011